Stewart Enterprises to resume stock repurchase program

Stewart Enterprises, Inc. (Nasdaq:STEI) announced today that the Company plans to resume purchases of its Class A common stock pursuant to its previously established stock repurchase program. The stock repurchase program was originally authorized in September 2007, subsequently expanded in December 2007 and June 2008, and permits the Company to spend up to $75.0 million to repurchase shares of its Class A common stock. As of July 31, 2010, $26.5 million remained available under the program. Open market purchases under the program were last made during the third fiscal quarter of 2008.

Thomas J. Crawford, Chief Executive Officer and President of the Company, said, "The Company continues to generate substantial operating cash flow. At current market price levels, we believe repurchases of the Company's stock offer an attractive opportunity to utilize our capital and enhance shareholder value."

Repurchases may be effected through open market purchases or in privately negotiated transactions at such times and in such amounts as management deems appropriate, depending on market conditions and other factors. The Company intends to use its available cash to fund share repurchases. The repurchase program does not obligate the Company to acquire any specific number of shares and may be suspended or terminated at any time.

Source:

Stewart Enterprises, Inc.

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.